Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
about
The role of EGFR-TKI for leptomeningeal metastases from non-small cell lung cancerMolecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future DirectionsDiagnosis and Treatment of Leptomeningeal Metastasis in Non-small Cell Lung CancerRecent Advancements of Treatment for Leptomeningeal CarcinomatosisProlonged response of meningeal carcinomatosis from non-small cell lung cancer to salvage intrathecal etoposide subsequent to failure of first-line methotrexate: a case report and literature reviewCarcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment.Impact of multimodality approach for patients with leptomeningeal metastases from solid tumorsLeptomeningeal metastases in breast cancer.Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib.Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer.Carcinomatous meningitis: Leptomeningeal metastases in solid tumorsIntrathecal chemotherapy as a treatment for leptomeningeal metastasis of non-small cell lung cancer: A pooled analysisConcurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic FactorsGemcitabine plus oxaliplatin for the treatment of leptomeningeal metastases of non-small cell lung cancer: A case report and review of the literature.Experimental Treatments for Leptomeningeal Metastases From Solid Malignancies.State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.Neoplastic Meningitis Due to Lung, Breast, and Melanoma Metastases.Treatment of Leptomeningeal Metastases in a Patient with Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation.Leptomeningeal disease: current diagnostic and therapeutic strategies.Back pain in a patient with lung cancer.Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy.Leptomeningeal metastasis from systemic cancer: Review and update on management.Treatment of leptomeningeal spread of NSCLC: a continuing challenge.Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.Chemical meningitis related to intra-CSF liposomal cytarabine.Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung.Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.[Efficacy and Security of Intrathecal with Methotrexate in the Treatment of Meningeal Carcinomatosis].An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments.EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours†
P2860
Q26740529-CC5B2C4C-80A1-4999-A362-D5DF614E4FFEQ26741320-5B9A1494-7CC2-473B-B097-2FAEDC56822DQ26781690-35B0BE6F-1F9E-43D7-9AF5-C81D1B0A137BQ26798009-D0EC7FB0-0EFA-4D8C-A4AA-4EB31A694D6CQ28082294-33746654-2B03-411A-A70B-D85E7072B45FQ33841560-E31DABCA-0883-43F0-B092-9009B2D01561Q34029965-F4634FFF-8CE2-4FFE-8745-26DC7FAE9F04Q34650605-1C7E9470-866B-4645-97B3-536A9784C785Q34772704-6571AFA9-685E-4FE0-BB88-DFCDF5CC4C4CQ35007620-6617D472-5492-4C6C-9C5B-5ABF93557844Q35879370-2FECD798-879B-4BAD-BA48-52F6DFADDC72Q36851197-C42149BB-48B5-4B1D-A272-9A45C5734BF3Q37107954-EE4E872C-5D38-403D-B808-E99839EA8FE9Q37394649-4156B046-1B9E-4482-80F4-9CFD4E2C0C08Q37409891-E967EEAB-E65E-4836-98F2-2499350115E6Q38113963-3E7863A9-A48F-45F8-A6A7-8997D70CEF31Q38971627-3B4DE934-6B28-41EB-BCF6-76D00E956D77Q38985340-1C24EB30-5270-4B4C-9C9A-546089A0F4CEQ39126735-9788025F-39D7-4E48-8F8A-92F257D2E195Q42668078-EAE26E46-CE1A-4D80-9C71-9928D9578E76Q42700664-68A830D5-DB80-44FF-BFE6-43EEB2AC0C07Q42731811-00893FC7-48A1-4A88-BB75-90E77672FFA2Q43589739-A0BA10A3-E1A0-4DAB-A7DD-75555740A41FQ43651159-3E6757C5-1401-4EE5-A02F-B188FFADD2A4Q44502804-BE5B7176-7CD1-448C-8EF4-B29E903B4BB5Q47133535-D2915098-755A-48C8-89CD-0961C4DF419FQ47428678-A058AD46-D5A5-4C84-8F3B-44B07ED007A7Q48427334-399B7BA7-FC85-469D-827C-47E373B4B01FQ48675213-C045A614-62F6-4ABE-8862-30D54B957038Q50066702-F61140EF-AF56-4A49-8E04-CFCFB2B5CE84Q50853655-8EA3A66D-98CA-41D5-BCA8-3BE8F07D1C3AQ52096930-D3645409-30AE-4D83-8F7E-AE001A9B88A3Q53096070-8005F176-CC6E-4D7F-89CC-BBD5B9E3B6EFQ53282846-87A2196B-3C7D-42BC-B98C-AE612C82DBE6Q55327976-7A018FC7-FD52-42AA-9A31-BA522AC3E8BEQ57578829-1AC4C0C1-B613-474B-BD4F-6ACAB28D21A4
P2860
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@ast
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@en
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@nl
type
label
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@ast
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@en
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@nl
prefLabel
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@ast
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@en
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@nl
P2093
P1433
P1476
Clinical outcomes of leptomeni ...... n the modern chemotherapy era.
@en
P2093
Jae Sung Kim
Jee Hyun Kim
Jeong-Ok Lee
Jin Hyun Park
Jin-Haeng Chung
Jong Seok Lee
Keun-Wook Lee
Soo-Mee Bang
Yu Jung Kim
P304
P356
10.1016/J.LUNGCAN.2011.11.022
P577
2011-12-18T00:00:00Z